Product Information
PIMECROLIMUS 1% CREAM is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $3.1902 per GM under NDC 68462060965. Its NADAC has been published 359 times since Oct 9, 2019.
FDA first approved this application on Aug 29, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/g
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462060965
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
8/19/2026
Active Ingredients
PIMECROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA211769FDA Approved
8/29/2019
TE Code
AB
On Market Since
8/29/2019
Pharmacological Classes
Price Statistics
The NADAC for PIMECROLIMUS 1% CREAM has been published 359 times since Oct 9, 2019, and over the history we have for it it has declined 56.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1902 per GM |
|---|---|
| All-time high | $7.6588 (Apr 15, 2020) |
| All-time low | $2.0962 (Nov 20, 2024) |
| 52-week high | $3.2132 |
| 52-week low | $2.6896 |
| Median price | $3.9123 |
| Average price | $4.1715 |
| Largest weekly change | -28.4% (Nov 20, 2024) |
| Weeks tracked | 359 |
| Tracking since | Oct 9, 2019 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 22% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIMECROLIMUS 1% CREAM?
The current National Average Drug Acquisition Cost (NADAC) for PIMECROLIMUS 1% CREAM, manufactured by Glenmark Pharmaceuticals Inc., USA, is $3.1902 per GM (NDC 68462060965), effective Aug 19, 2026.
How has the price of PIMECROLIMUS 1% CREAM changed over time?
Over the history we have for it, the NADAC for PIMECROLIMUS 1% CREAM has declined 56.2%. It has been tracked across 359 weekly CMS publications since Oct 9, 2019.
What are the highest and lowest recorded NADAC prices for PIMECROLIMUS 1% CREAM?
Since Oct 9, 2019, the NADAC for PIMECROLIMUS 1% CREAM has ranged from a low of $2.0962 (Nov 20, 2024) to a high of $7.6588 (Apr 15, 2020), with a median of $3.9123 per GM.
Are there cheaper alternatives to PIMECROLIMUS 1% CREAM?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIMECROLIMUS 1% CREAM, is $2.4853 per GM — about 22% below PIMECROLIMUS 1% CREAM.
Who manufactures PIMECROLIMUS 1% CREAM?
PIMECROLIMUS 1% CREAM (NDC 68462060965) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.